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Abstract
Background: Cardiac surgical procedures are associated with postoperative neurological complications such as
cognitive decline and delirium, which can complicate recovery and impair quality of life. Perioperative depression
and anxiety may be associated with increased mortality after cardiac surgeries. Surgical prehabilitation is an
emerging concept that includes preoperative interventions to potentially reduce postoperative complications.
While most current prehabilitation interventions focus on optimizing physical health, mind–body interventions
are an area of growing interest. Preoperative mind–body interventions such as Isha Kriya meditation, may hold
significant potential to improve postsurgical outcomes.
Methods: This is a prospective, randomized controlled feasibility trial. A total of 40 adult patients undergoing
cardiac surgery will be randomized to one of three study groups. Participants randomized to either of the two
intervention groups will receive meditative intervention: (1) commencing two weeks before surgery; or (2)
commencing only from the day after surgery. Meditative intervention will last for four weeks after the surgery in
these groups. Participants in the third control group will receive the current standard of care with no meditative
intervention. All participants will undergo assessments using neurocognitive, sleep, depression, anxiety, and pain
questionnaires at various time points in the perioperative period. Blood samples will be collected at baseline,
preoperatively, and postoperatively to assess for inflammatory biomarkers. The primary aim of this trial is to assess
the feasibility of implementing a perioperative meditative intervention program. Other objectives include studying
the effect of meditation on postoperative pain, sleep, psychological wellbeing, cognitive function, and delirium.
These will be used to calculate effect size to design future studies.
Discussion: This study serves as the first step towards understanding the feasibility of implementing a mind–body
intervention as a prehabilitative intervention to improve postoperative surgical outcomes after cardiac surgery.
Trial registration: Clinicaltrials.gov, NCT03198039. Registered on 23 June 2017.
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Background
Hospital admissions and surgeries have been increasing
with time due to a shifting pattern of disease prevalence
from infectious diseases to lifestyle disorders [1]. Cardio-
vascular diseases are increasingly seen in the elderly with
various co-morbidities such as hypertension, diabetes,
and renal impairment; they often require surgery [2]. Pa-
tients who undergo cardiac surgery can have significant
pain, sleep impairment [3, 4], postoperative delirium
(POD), and cognitive decline (POCD) [5], which can
lead to increased length of hospital stay and increased
healthcare expenses. Postoperative pain and sleep im-
pairment can have a direct impact on postoperative de-
lirium and cognitive recovery and the complications can
be long lasting which can negatively impact the quality
of life [6]. Evidence suggests that non-surgical preopera-
tive patient factors such as psychological characteristics,
personality traits, and preoperative cognitive impairment
may also play a significant role in surgical recovery and
patient satisfaction [7, 8]. Anxiety and depression in the
perioperative period have been associated with increased
mortality after cardiac surgery [9]. Thus, there is a
definitive role for mind–body prehabilitative interven-
tions to improve postoperative outcomes.
Surgical prehabilitation is an emerging concept that re-
fers to interventions in the preoperative period aimed at
improving postsurgical outcomes. These are pre-emptive
strategies including physical therapies, pharmacological,
and non-pharmacological measures to improve outcomes.
In their review, Culley et al. mentioned that surgery can
be compared to a fire and prehabilitation as a fire retard-
ant [10]. Mind–body interventions include a wide range
of practices and therapies that positively impact the mind’s
influence on physical health [11]. Mind–body interven-
tions have been shown to promote sleep and reduce
postoperative delirium [10, 12, 13]. Integrative cardiac
wellness programs can have a positive impact and can
promote patient’s innate ability to heal [14].
In an expanded systematic review, it was reported that
relaxation interventions and hypnosis could have a posi-
tive influence on psychological wellbeing [15]. Only two
studies included in the expanded systematic review were
of high quality [16, 17]. Most of the other studies did
not have randomization or blinding of the outcome
assessors, leading to inconclusive results. Lack of report-
ing pain scores was a significant limitation of the studies.
Another systematic review of randomized controlled
trials examining relaxation for acute pain management
similarly concluded that though there was “some weak
evidence” to support the use of these therapies, the data
were inconclusive, in part owing to methodological limi-
tation [18]. The mind–body intervention was used only
one day before surgery in most of the studies included
in the meta-analysis. Another review provides evidence
supporting the efficacy of mind–body interventions for
depression, anxiety, and stress [19].
A recent study done by Kiran et al. explored the role
of Rajyoga meditation, a certain type of meditation for
the modulation of anxiety and serum cortisol in patients
undergoing coronary artery bypass surgery. This study
showed that the addition of meditation helped patients
in coping with stress and they found a significant decline
in anxiety levels in the postoperative period. They also
found a favorable modulation of serum cortisol levels
with the meditation [12]. The above studies demonstrate
that breathing and meditative techniques have a bio-
logical plausibility to favorably impact outcomes. They
have been shown to have established use in non-surgical
chronic disease states such as fibromyalgia, cancer,
hypertension, and psoriasis [20].
Finding a meditation technique that has the optimal
components and that is easy enough to ensure compli-
ance is a challenge. Meditation encompasses a family of
different systems and practices including yoga medita-
tion, mantra meditation, tai chi, mindfulness meditation,
etc. Isha Kriya (IK) is a form of guided meditation that
involves thought, focus, and mindful slow breathing.
This regimen was chosen because it excels in simplicity
and is suitable to introduce meditation to beginners.
Regarding timing and duration of application of these
prehabilitative measures, research groups have studied
interventions of durations in the range of 1–30 days
before surgery [21, 22]. In earlier studies that examined
psychosocial support, a duration as short as one day be-
fore surgery was used for intervention [18]. In preopera-
tive exercise therapies, a 3–4-week period was used.
Although optimal duration is not clearly defined, based
on the current scheduling practices for surgery, two
weeks is a reasonable preoperative timeframe to investi-
gate. This randomized, controlled pilot trial will examine
the feasibility of implementing a prehabilitative medita-
tion program in the perioperative period.
Methods / design
Study registration
This study protocol was approved by the Committee on
Clinical Investigations Institutional Review Board (IRB)
at Beth Israel Deaconess Medical Center (Protocol
2017P000239). This trial was registered with the U.S.
National Institutes of Health on clinicaltrials.gov with
the trial identification number NCT03198039 on 23 June
2017. The trial is currently ongoing and recruiting.
Study design
This study is a prospective, randomized, controlled,
assessor blinded, single-center trial with three arms,
including two experimental arms and one control arm.
The study population will include adult patients
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undergoing coronary artery bypass grafting (CABG),
valve surgeries, and/or aortic surgery at Beth Israel Dea-
coness Medical Center, a tertiary care hospital. Informed
consent will be obtained before initiation of study proce-
dures. Further, all trial conduct and reporting will be in
accordance with components as described in the SPIRIT
(Standard Protocol Items: Recommendations for Inter-
ventional Trials) checklist [23, 24].
Aims and objectives
We hypothesized that it is feasible to implement a medi-
tation program aimed at improving outcomes in the
adult cardiac surgical population. The primary aim of
this pilot study is to assess the feasibility of implement-
ing a meditation program in the preoperative period,
which will be measured in terms of adherence of the
participants to the meditative regimen. Our study will
further explore whether a perioperative meditation regi-
men can result in improvement in postoperative out-
comes including pain, sleep, psychological wellbeing,
cognitive function, and delirium. Given the pilot nature
of the proposed trial, all secondary outcomes will be
considered hypothesis generating only.
Eligibility criteria
Patients aged ≥ 18 years, undergoing CABG, valve surgery,
or isolated aortic surgery will be included in the study. To
allow implementation of a prehabilitative strategy, surger-
ies must be scheduled at least 14 days after enrollment
(Table 1).
Patients undergoing urgent or emergent procedures or
those undergoing only minimally invasive cardiac proce-
dures will be excluded. Non-English-speaking patients and
those with significant visual impairment will also be ex-
cluded, as these factors preclude performing neurocogni-
tive assessments. Patients who do not have high-school
level or the equivalent educational attainment, patients
with moderate to severe cognitive impairment as defined
by baseline Montreal Cognitive Assessment (MoCA) < 10
and those on cognition-enhancing drugs will be excluded.
Patients with a history of cognitive impairment and
psychiatric illnesses will be excluded. Patients who are
actively taking pain medications will be excluded. Patients
who are currently enrolled in another interventional study
that could potentially impact the primary outcome will
also be excluded from the study.
Recruitment and randomization
Individuals will be identified from perioperative surgical
consult lists and cardiac surgery clinic visit schedules. If
a candidate is eligible for enrollment, he or she will be
approached by a member of the research team to discuss
the study in detail. Written informed consent will be
obtained before initiation of any study procedures.
After obtaining consent, enrolled participants will be
randomly assigned to one of three groups using block
randomization in a 1:1:1 allocation. REDCap will be
utilized to implement the randomization schema while
maintaining the blind. REDCap is a secure software
designed for rapid data capture tools using metadata
table referenced by presentation-level operational mod-
ules [24]. Patients will be randomized to one of the
following groups:
 Group 1: Patients are asked to meditate twice daily,
starting from least two weeks before surgery, up
until four weeks after surgery;
 Group 2: Patients are asked to meditate twice daily
from the day after surgery until four weeks after
surgery;
 Group 3: Patients in the control group will undergo
surgery and subsequent hospital stay according to
the current standard of care, which does not include
meditation.
Patients who are actively meditating previously and
are willing to participate in the study will be asked to re-
frain from meditating during the study period if they are
randomized to the control group. They will be required
Table 1 Study inclusion and exclusion criteria
Inclusion criteria
1. Aged ≥ 18 years
2. Undergoing any of the following types of cardiac surgery: CABG
with or without valve surgery (aortic and/or mitral); isolated valve
surgery; isolated aortic surgery
3. Surgery scheduled for at least 14 days after enrollment
Exclusion criteria
1. Urgent and/or emergent surgery
2. Non-English speaking
3. Pre-existing history of psychiatric illness as documented in the
medical record or divulged in history taking in pre-enrollment patient
interview, such as anxiety, depression, or bipolar disorder
4. History of cerebrovascular accident or recent history (< 3 months)
of seizures
5. History of dementia, Parkinson’s disease, Alzheimer’s disease, or
other forms of cognitive decline
6. Current use of cognition-enhancing drugs
7. Current management for chronic pain
8. Currently enrolled in another interventional study that could
impact the primary outcome, as determined by the PI
9. Educational attainment below high school level or equivalent
10. Significant visual impairment
Preoperative dropout criteria
1. Cognitive impairment as defined by MoCA score < 10
2. DASS-21 depression score > 10
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to follow the IK meditation schedule during the period
of study participation if they are randomized to one of
the intervention groups.
The inclusion of a control group will allow for quantifi-
cation of the natural history of surgery and postoperative
complications. Further, we are utilizing two interventional
groups to assess whether a prehabilitative strategy results
in differences as compared to a mitigation strategy. Two
intervention groups will also help us determine the opti-
mal duration of intervention and the possible impact of
duration on compliance and other secondary outcomes.
Study intervention
IK meditation is a type of meditation that focuses on
thought and mindful breathing and takes approximately 12
min to complete. This regimen was chosen because it ex-
cels in simplicity and is a great way to introduce meditation
to beginners. Further, it does not incorporate any spiritual
or religious focus. “Kriya” means an internal action, which
is focusing on a specific thought in this case [25].
In brief, the participant first begins preparing for the
IK practice by sitting in a cross-legged posture or sitting
in a chair, spine comfortably erect, hands on their thighs,
palms facing up, face slightly upturned, eyes closed, all
while keeping a mild focus between the eyebrows. He or
she can start meditating by slowly inhaling and exhaling
while mentally focusing on the thoughts “I am not the
body” during inhalation and “I am not even the mind”
during exhalation. This is continued for 7 min. This is
followed by uttering a long “Ahh” sound seven times.
The individuals are instructed to exhale through the
sound and utter the sound loud enough to feel a vi-
bration around the mid-abdomen. The third step in
the process is to sit still for 5 min with the eyes
closed, as detailed in Fig. 1. This practice is to be re-
peated twice daily.
At the time of enrollment, individuals randomized to
Groups 1 and 2 are introduced to the meditation by a
trained unblinded study team member. The participant
is walked through the instructions and is then allowed
to practice the technique with the instructor’s guidance.
Participants who are randomized to meditate only after
surgery will be asked to complete the practice once to
ensure they are comfortable with the instructions and to
otherwise refrain from meditating until after surgery.
Unblinded study team members will not conduct any
other subsequent subjective study assessments to reduce
any bias associated with interpreting results.
Study outcomes
The primary outcome of the study is to assess the
feasibility of implementing a meditation routine in the
perioperative period. This will be evaluated using the
adherence data from patients’ meditation diary. Second-
ary exploratory outcomes include effects of the interven-
tion on pain, sleep, psychological wellbeing, cognitive
function, and delirium. A number of tools, including pain
scores, questionnaires for cognition and delirium
Fig. 1 Meditation instructions. Participants in either mediation group are provided with the instructions depicted here. In short, this includes
preparation and three stages in which the participant mindfully inhales and exhales slowly for 7 min, produces the sound “Ahh” seven times, and
finishes with 5 min of being quiet
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assessment, depression and anxiety questionnaire, sleep
questionnaires, total opioid consumption and supplemental
analgesic requirements in the first 48 h postoperatively,
Intensive Care Unit (ICU) stay, and hospital length of stay,
will be used to measure the secondary outcomes. In
addition, we will also evaluate inflammatory biomarkers
measured in plasma. All secondary outcomes will be consid-
ered hypothesis generating and interpreted as such (Fig. 2).
Meditation adherence
To assess study feasibility, we will evaluate adherence to
the study protocol. Patients in the meditation groups
will be provided with meditation diaries, where they will
be asked to record their daily meditation sessions.
Adherence to the meditation schedule will be assessed
by calculating the total number of meditation sessions
completed divided by the total number of sessions
required as per protocol.
Neurocognitive and psychological assessments
A trained research team member who remains blinded
to treatment allocation will perform baseline cognitive,
delirium, anxiety, and depression assessments. Cognitive
function will be assessed using the Montreal Cognitive
Assessment (MoCA), supplemented with days of the
week (DOW) and months of the year (MOY) for
additional attention testing. The Delirium Symptom
Interview (DSI) will be used to capture delirium. The
Depression, Anxiety, and Stress scale (DASS-21) will
be used to assess the baseline psychological state.
Using data from the cognitive testing and DSI, the
researcher will complete the Confusion Assessment
Method (CAM), which includes an assessment of
delirium using the CAM diagnostic algorithm. If this
baseline assessment shows a DASS-21 depression
score > 10 or MoCA score < 10, the individual will be
excluded from the study.
Fig. 2 SPIRIT figure. The schedule of enrolment, interventions, and assessments in the study
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To assess the changes over time, or the possible effect of
perioperative meditation, a telephonic MoCA (t-MOCA)
will be administered preoperatively within 24 h before
surgery. These assessments will take place before ini-
tiation of any sedatives or other medications that may
affect the patient’s performance or ability to complete
the assessment.
On each postoperative day during the hospital stay, a
blinded research team member will administer a stand-
ard cognitive assessment, including DOW, MOY, CAM,
and the DSI. If an individual is intubated postoperatively,
a CAM-ICU will be performed instead of a CAM assess-
ment. If daily assessments have plateaued for three con-
secutive days and the patient remains CAM-negative
each day, assessments will then be completed every
other day if the individual remains CAM-negative, until
the date of discharge. On the day of discharge, the
MoCA, DOW, MOY, CAM, DSI, and the DASS-21 will
be completed.
A follow-up assessment will be administered at one
month (± seven days) after the date of surgery. These
will be completed by a blinded research team member
via telephone and will include a T-MoCA, DOW, MOY,
CAM, DSI, and DASS-21. Medications that were taken
6 h before the assessments, as reported per the individ-
ual, will be documented at all time points.
Sleep questionnaires
The Pittsburgh Sleep Quality Index (PSQI), which mea-
sures quality and patterns of sleep during the past
month, will be completed at baseline and at the
one-month follow-up. The PROMIS – Sleep Disturbance
and the PROMIS – Sleep Related Impairment question-
naires will be completed weekly from baseline until the
day of surgery, preoperatively within 24 h of surgery and
weekly after surgery through the one-month follow-up.
These questionnaires may be completed in person or via
telephone.
Blood collection
Blood will be collected to investigate whether the use
of a meditation regimen results in a favorable modu-
lation of inflammatory and stress biomarkers second-
ary to surgery. Collection will occur at baseline,
preoperatively (within 24 h before surgery), and on
postoperative day 2 for all participants. At each time,
approximately 10 cc will be collected. All specimens
will be centrifuged, plasma will be aliquoted into
smaller cryovials, and frozen at − 80 °C for future use.
These specimens will be stored in a biorepository
which will be later used to analyze the markers of
inflammation.
Postoperative pain assessment
Postoperative pain will be assessed with a standard
11-point scale and by pain medication requirements.
Pain scores will be obtained during the entire hospital
stay by asking the individual and collected from the
medical record when documented clinically. Pain medi-
cation intake in the first 48 h postoperatively will be
ascertained from the medical record.
Satisfaction survey
At the time of the one-month follow-up assessment, or
if a participant withdraws from the study, the individuals
will be asked to complete a brief satisfaction survey. This
survey asks about the patients’ perception of their
thinking, memory, attention, and overall wellbeing. If
participants were randomized to the control group, they
will be asked whether they would be interested in a
meditation regime. Participants randomized to either
meditation group will be asked about their experience
completing the meditation practices, as well as any other
feedback related to the study intervention, which will be
considered during design of a future study.
Adverse event monitoring
Since the study participants are undergoing high-risk
surgery, it is expected that they may have several adverse
health events during their hospital course unrelated to
the study intervention. Further, the study intervention is
non-invasive and carries minimal risk; therefore, we will
limit the scope of our adverse event (AE) reporting to all
serious AEs related to study procedures or unexpected
non-serious AEs believed to be related to the study
procedures. An AE includes changes in the patient’s
stress and anxiety; therefore, we will monitor and report
abnormal changes in the DASS-21. If the score from any
of the three categories (depression, anxiety, stress) falls
into the “Severe” or “Extremely Severe” range, the
participant will be dropped out of the study for further
clinical evaluation and management.
Data collection and management
Data will be collected and stored on REDCap. REDCap
is a web-based application that allows for customized
data collection and entry [24]. The study team will build
and maintain the electronic case report forms on RED-
Cap as well as ensure data completeness and quality
periodically by means of internal audits. All efforts will
be made to maintain the confidentiality of patient data.
Statistical analysis
In this feasibility study, a convenience sample of 30
participants (10 per group) will be enrolled to assess
feasibility. While we expect it to be very rare, it is pos-
sible that some individuals may be determined ineligible
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after signing consent (because of their baseline MoCA
or DASS-21 depression scores). Therefore, we plan to
enroll enough patients to obtain data from 30 random-
ized participants. We estimate that approximately 40
patients may be enrolled to account for dropouts, loss of
follow-up, and to achieve this sample size of 30. No a
priori power calculation was performed.
Since the primary outcome of the study assesses the
overall feasibility of conducting the trial, our descrip-
tive study will record the proportion of patients eli-
gible who meet inclusion without exclusion criteria
and decide to participate. The statistics for overall proto-
col adherence to the intervention will be recorded by
reporting the total number of sessions completed out
of that required per protocol. We will also assess the
total number of questionnaires completed out of the
total required.
Descriptive statistics of data will be performed. Categor-
ical data will be reported as proportions and assessed with
the use of a chi-square or Fisher’s exact test. Continuous
data will be reported as means ± standard deviations
or median (quartile 1 and quartile 3) depending on
distribution and assessed using analysis of variance
(ANOVA). We estimate that with a small sample size
it may not be acceptable to assume normality and
may be appropriate to use a non-parametric equiva-
lent such as Kruskal–Wallis test when appropriate. A
trajectory analysis will be performed to assess changes
in the presence of delirium or changes in cognitive
function over time. Since the secondary outcomes are
exploratory in nature, all tests will be two-sided, with
p values < 0.05 considered statistically significant.
Data will be analyzed using SAS 9.4 (SAS Institute
Inc., Cary, NC, USA) or later. Our primary analysis
will be conducted using the intention-to-treat
principle. All trial reporting will adhere to the Stand-
ard Protocol Items: Recommendations for Interven-
tional Trials (SPIRIT; Additional file 1: Table S1).
Discussion
Significance
Despite the growing popularity of mind–body prac-
tices, few studies have investigated their use in the
perioperative period during complex surgeries such as
cardiac cases. Therefore, using a comparative ran-
domized controlled trial design, this study will lay the
foundation to investigate mind–body practices in the
perioperative period by exploring the feasibility of IK
meditation in patients undergoing heart surgery.
Future direction
A reasonable compliance to the meditation schedule in
the intervention groups will denote feasibility and will
lay down the foundation for a more elaborate study.
Comparison between the two intervention groups will
provide an estimate of the optimal timeframe and
duration of the intervention necessary to achieve the
desirable outcomes. Sensitive, quantitative tools have
been used to examine and measure the magnitude of
effect for various outcomes such as pain, sleep, delirium,
cognitive decline, depression, anxiety, and inflammatory
biomarkers. One or more positive outcomes along with
their respective effect sizes will inform on the end-
points and sample size of an adequately powered
study in the future.
Limitations
One potential limitation is the possibility for loss to
follow-up. This could significantly impact the study,
given the relatively small sample size. A flexible time-
frame for the one-month follow-up will help
minimize this issue. Further, we have accounted for
loss of follow-up and dropouts and have planned to
enroll 40 patients in order to achieve a sample size of
30 participants. This study includes only one aca-
demic medical center and its patient population.
While we are in an urban area, the study population
may not be a completely representative sample of
those who undergo these types of procedures. Delir-
ium and pain may be transient and it might be diffi-
cult to measure them accurately despite the use of
sensitive tools. Randomization should help minimize
this limitation.
Ethics and dissemination
This study has been approved by the Committee on
Clinical Investigations, Institutional Review Board at
Beth Israel Deaconess Medical Center (Protocol
2017-P-000239). Written informed consent will be
obtained from all individuals before initiation of study
procedures.
Results of the trial will be reported in national and
international meetings, as well as in scientific journals.
There are no plans to individually notify participants re-
garding the results of this study. If the feasibility of
implementing prehabilitative meditation program in the
perioperative period is proven by the study, larger stud-
ies can be undertaken to study the effect of meditation
in sleep, postoperative pain and cognitive decline.
Trial status
This trial is currently recruiting participants. Recruit-
ment is anticipated to be completed by July 2019.
Additional file
Additional file 1: Table S1. SPIRIT Checklist for the Study. (DOC 123 kb)
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